Hiv/aids Vaccine Development
$0Z01FY2003AINIH
Niaid Extramural Activities
Investigators
Linked publications & trials
Paper 23388006Paper 19420074Paper 17391815Paper 17325604Paper 17113201Paper 17109336Paper 16943292Paper 16763152Paper 16735692Paper 16622001Paper 16569729Paper 15994776Paper 15956548Paper 15858035Paper 15837367Paper 15795244Paper 15761255Paper 15709015Paper 15613305Paper 15596858Paper 15220422Paper 15128818Paper 15047819Paper 14985706Paper 14610198Paper 12928404Paper 12885892Paper 11991964Paper 11739689Paper 11312370
Abstract
A vaccine against HIV would provide a simple, low-cost means of controlling the spread of AIDS worldwide, particularly in the developing world where other treatments are unavailable. This research study aims to improve immunogenicity of HIV vaccines by selective mutation of HIV proteins and development of effective adjuvants. Promising candidates are being tested in both animal studies and human clinical trials.
View original record on NIH RePORTER →